Development of a New Treatment for Alzheimer's Disease and Parkinson's Disease Using Anti-Aggregatory β-Synuclein-Derived Peptides

By Windisch M.   Hutter-Paier B.   Rockenstein E.   Hashimoto M.   Mallory M.   Masliah E.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 63-70

Humana Press, Inc

Access to resources Recommend Favorite

Is Alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?

By  

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 556-561

Bentham Science Publishers

Access to resources Recommend Favorite

Is alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?

By  

Current Alzheimer Research, Vol. 4, Iss. 4, 2007-09 ,pp. : 446-457

Bentham Science Publishers

Access to resources Recommend Favorite

Immunocytochemical localization of synphilin-1, an α-synuclein-associated protein, in neurodegenerative disorders

By Wakabayashi Koichi   Engelender Simone   Tanaka Yuji   Yoshimoto Makoto   Mori Fumiaki   Tsuji Shoji   Ross Christopher   Takahashi Hitoshi  

Acta Neuropathologica, Vol. 103, Iss. 3, 2002-03 ,pp. : 209-214

Springer Publishing Company

Access to resources Recommend Favorite

The Expression of Activity-Dependent Neuroprotective Protein (ADNP) is Regulated by Brain Damage and Treatment of Mice with the ADNP Derived Peptide, NAP, Reduces the Severity of Traumatic Head Injury

By  

Current Alzheimer Research, Vol. 2, Iss. 2, 2005-04 ,pp. : 149-153

Bentham Science Publishers

Access to resources Recommend Favorite